Citations(0)

Content

How to Cite This Article

Download Download [ PDF ]

Email Send to a friend

Page Views Page Views(1123)

Facebook ShareFacebook Share

Twitter ShareTwitter Share

Year : 2018 Month : March Volume : 7 Issue : 10 Page : 1271-1274

VACUUM ASSISTED HYDROCOLLOID DRESSING - OUR EXPERIENCE.

Vasudev Murthy Kumar1 Chethan Narayanappa2

1Associate Professor, Department of General Surgery, Akash Institute of Medical Sciences and Research Centre, Devanahalli.
2Assistant Professor, Department of General Surgery, Akash Institute of Medical Sciences and Research Centre, Devanahalli.

CORRESPONDING AUTHOR

Dr. Vasudev Murthy Kumar,
Email : murthy_dbp@yahoo.com

ABSTRACT

Corresponding Author:
Dr. Vasudev Murthy Kumar,
#525, Tank Road, Doddballapur-561203,
Bangalore Rural District.
E-mail: murthy_dbp@yahoo.com

ABSTRACT

BACKGROUND

Chronic ulcers are responsible for significant morbidity and mortality all over the world. Management of these ulcers is constantly updated with newer advancements and newer dressing materials. Vacuum-assisted hydrocolloid dressing (VAHCD) is one such dressing, which combines the advantages of hydrocolloid support with provision of sub-atmospheric pressure by vacuum. Our study is an attempt to evaluate the efficacy of VAHCD in large chronic ulcers.

The objective of this study is to evaluate the efficacy of VAHCD on large chronic ulcers.

MATERIALS AND METHODS

This study was conducted as descriptive study. Patients with ulcers more than 10 * 10 cm size, who attended in the dept. were included in the study. Patient’s consent was taken. All these patients were done VAHCD and results were recorded.

RESULTS

28 patients were included in the study, of which 13 were of 2 to 6 months duration. 20 ulcers were of size from 10 to 20 cm in largest dimension. After dressing with VAHCD, majority of ulcers showed more than 1 cm decrease in size per dressing and depth of ulcers were filled up within 1 - 2 dressings.

CONCLUSION

Vacuum-Assisted Hydrocolloid Dressing is an efficient and overall cost-effective method in management of chronic ulcers.

KEYWORDS

Vacuum-Assisted Hydrocolloid Dressing (VAHCD), Chronic Ulcer, Subatmospheric Pressure.

BACKGROUND

The association of chronic foot ulcers with a high incidence of amputation, morbidity and mortality is well documented in the International Literature including guidelines from the American Diabetes Association, the International Consensus Panel of Diabetic Ulcers, and the German Literature on Diabetic Foot Syndrome.1,2,3 A brief review of the pathophysiology of diabetic ulcers and an understanding of the chronic wounds will facilitate decisions related to the use of new technologies. The following overview of new technology related to diabetic foot ulcer care will summarise relevant information related to chronic wounds and assist in defining a chronic wound and its management using vacuum-assisted hydrocolloid dressing. VAHCD is a non-invasive procedure that utilises negative pressure to remove fluid from the open wounds through sealed dressings.

Chronic Wound Healing

The cellular mechanism of wound repair in the acute wound has been extensively studied and documented in the medical literature.4,5,6The inflammatory, proliferative (Granulation phase) and remodelling phases can be categorised according

to the activity of their cellular components including cytokines, chemical mediators and cellular components.7 Intrinsic medical conditions or extrinsic environmental factors rarely affect the repair process in the healthy individual. The chronic wound, in contrast to the above, has phases of repair that do not follow the expected sequence of healing. Wound treatment experts in the United States have made attempts to define chronic wounds.8 Intrinsic, extrinsic and wound environment factors must be simultaneously treated for optimal outcomes. Intrinsic factors include the patient’s medical status, prescribed medications and concomitant disease. Extrinsic factors concern repetitive trauma, off-loading and pressure reduction.

 

Definition of Chronic Wounds

15% - 20% of patients with chronic wounds does not respond to conventional therapy and may require the use of advanced technologies to stimulate and expedite tissue repair. The surgeon needs to differentiate between a responding chronic wound, which will close with conventional treatment and a truly non-responding wound which will require a different approach such as vacuum-assisted hydrocolloid dressing.

Pecoraro et al9 determined that not all diabetic ulcers are responders. Those ulcers not showing a reduction in size in a one-month treatment period with good pressure reduction and ulcer therapy can be classified as non-responders. Furthermore, Silhi et al10 determined that approximately 15% of all diabetics under good control would still not demonstrate normal healing rates. The delay in wound repair may be attributable to endogenous wound factors including senescent cells, absence of growth factors and other cellular abnormalities. Debridement of senescent cells, non-viable tissue, fibrotic tissue, wound debris and other unwanted wound components may significantly expedite wound closure, while increasing the availability of viable cells able to produce and respond to growth factors and other cytokines. Debridement and its correlation to the significant increase in wound closure, particularly when followed by the application of negative pressure to wound bed. The presence of a prolonged inflammatory response may further delay closure by promoting ongoing activity of matrix-metalloproteinases (MMP). High levels of MMP activity may contribute to protein and growth factor degradation. Repetitive trauma and high levels of bacterial colonisation may result in increased inflammation activity with an associated influx of macrophages and neutrophils, the negative pressure helps in decreased bacterial burden from the wound. Appropriate levels of MMP activity during the phases of wound repair are known to promote wound repair, while prolonged levels may delay closure through matrix, growth factor and growth factor receptor degradation.11

Advanced Technology for Chronic Ulcers

The use of advanced technology like vacuum-assisted hydrocolloid dressing may assist with wound closure in the diabetic and non-diabetic patient. Based on medical literature, the clinician should be able to determine within the first few weeks of treatment whether a wound will respond to conventional therapies (responders) or remain chronic (non-responder). Available literature suggests that a visible decrease in wound size during the first few weeks of administering appropriate wound care is an indicator of chronicity. Wounds that decrease in size by greater than 0.109 cm per week have been found to correlate with responsive wounds, while rates less than 0.032 cm per week are classified as non-responders.12 A decrease in surface area of less than 10% per month may also correlate with non-responding chronic wounds. Once a surgeon has established the status of a wound as being chronic, advanced modalities may be selected to improve treatment and cost outcomes.

Vacuum-Assisted Hydrocolloid Dressing- Relevance to Chronic Foot Ulcers

Application of sub-atmospheric pressure to wound bed was proposed more recently in 1993 by Fleischmann and colleagues. Chen and colleagues showed that vascular endothelial cell growth (VEGF) factor pathway was stimulated. Hydrocolloid is a gel forming agent that contains Sodium carboxymethylcellulose, Gelatin. This formulation is combined with elastomers, adhesives and spread over a polyurethane foam. This hydrocolloid sheet forms an absorbent, self-adhesive, waterproof wafer and a wet tack. They absorb exudates and form a less viscous mobile gel, which is sucked out of the dressing. This dressing removes exudates from wounds by negative pressure of about 15 - 20 mmHg, decreases bacterial burden, provides a moist environment, reduces the peripheral oedema around the ulcer, promotes angiogenesis, helps in early closure of the wound. Indications for VAHCD include Acute, Chronic and traumatic Ulcers, Ulcers free of necrotic tissue and Pressure ulcers.

 

 

Objective

To evaluate the efficacy of VAHCD on large chronic ulcers.

MATERIALS AND METHODS

The study was conducted as descriptive study over 02 years from June 2014 to May 2016. Patients presenting to hospital with chronic lower limb ulcers of size more than 10 * 10 cm, both diabetic and non-diabetic wounds were included in the study. Chronic ulcers are defined as ulcers of more than 4 weeks duration. Patients with smaller ulcers, acute ulcers, ulcers with osteomyelitis and malignant ulcers were excluded from the study. Preliminary data was obtained.

VAHCD Procedure

The wound is debrided first and made free of necrotic tissue, under local anaesthesia closed suction drain was inserted, hydrocolloid sheet was fashioned to cover the entire wound with 1 cm covering over the margin of the wound. This is further covered with transparent adhesive dressing (opsite). A regular dressing is done over this. Negative suction is applied continuously.

Drains are discarded daily. Wound inspection was done on 4th - 5th day and dressing was changed entirely. Supportive measures were provided in the form of control of diabetes, immobilisation of the part, sensitivity based antibiotics, nutritional supplementation and drain care. Changes were documented based on size of the wound, granulation tissue, depth of the wound and surrounding skin texture. The results were tabulated. Once the size of wound was reduced or 6 - 8 VAHCD dressings were attempted, ulcers were managed with regular dressings, secondary suturing and split skin grafting.

These procedures were both as an inpatient and outpatient basis. All these patients were followed up for 6 months after complete closure of ulcers.

 

RESULTS

A total of 28 cases were included in the study. The general characteristics of these patients are as shown in table.

Sl. No.

General Characteristics

Size

Percent

01

Age:

< 20

20 – 40

> 40

 

0

15

13

 

0

53.5

46.5

 

Total

28

100

02

Sex:

Male

Female

 

25

03

 

89

11

 

Total

28

100

03

Duration of ulcer:

4 wks to 2 months

2 to 6 months

>6 months

 

12

13

03

 

43

46

11

 

Total

28

100

04

Diabetes:

Present

Absent

 

18

10

 

64

36

 

Total

28

100

 

The size of the ulcers (larger dimension- vertical/horizontal) prior to VAHCD were as follows-

10 to 20 cm                         -               20           (71.5%)

  • 20 cm                                     -               08           (28.5%)

All the patients were done VAHCD after debriding the necrotic tissue. Dressing was done as described earlier and was changed once in 03 to 05 days depending on soakage of dressing. The response noted were as follows-

Change in Size of ulcers-

 

After 1st Dressing

  • > 2 cm                                            -               10           (36%)
  • 01 - 02 cm                     -               18           (64%)
  • < 01 cm                          -               00

 

After 2nd Dressing

  • > 2 cm                                            -               12           (43%)
  • 01 - 02                           -               16           (57%)
  • < 01 cm                          -               00

 

Number of Dressings for ulcer to reach < 5 cm size

  • 07 - 08                           -               06           (21.5%)
  • 04 - 06                           -               16           (57%)
  • 02 - 03                           -               02           (21.5%)

 

04 cases which were > 05 * 05 cm even after 08 dressings were posted for split skin grafting. Depth of ulcers covered till surface within 01 - 02 dressings. Average duration of hospital stay for these patients was 8.5 days (range from 04 to 25 days).

The result of VAHCD on ulcer is shown in Photo 1 and 2.

Photo 1. Ulcer following Debridement of  Necrotising Fasciitis (6 Wks Old)


Photo 2. Changes Seen in Ulcer   after Two VAHCD


DISCUSSION

Fleischmann and colleagues described the use of vacuum-assisted closure in treatment of 25 patients with compartment syndromes of the lower limb. The average duration of the vacuum therapy treatment for the patients with compartment syndrome was 12.7 (4 - 31) days with 2.1 (1 - 8) dressing changes per patient. These wounds were subsequently either closed by secondary suturing (n= 20) or by skin grafts following partial closure by suturing (n= 5).13

Same author also published the use of same in 313 patients with acute and chronic infections of various types. The average duration of vacuum therapy in the treatment of the 313 patients with infected wounds was 16.7 days with an average of 3.1 dressing changes. Of the 203 wounds with acute infections, the majority were subsequently closed by secondary suturing (65.5%) and the remainder by spontaneous epithelialisation (17.2%), skin grafting (12.3%) or flap transfer (2%). Six patients (3%) died. Infection recurred in 3.9% and was managed using another treatment.14 Though this study shows lesser number of dressings per patient and use of secondary suturing, our study focused on large ulcers and hence they required more dressings.

Mullner et al described the results of a prospective trial involving 45 patients with soft tissue injuries with use of vacuum-assisted closure techniques. They reported that in 38/45 patients (84%) the use of the vacuum sealing technique following irrigation and debridement decreased the dimensions of the initial wound, thus facilitating healing time and the eradication of any pre-existing infection.15

Papers on use of vacuum-assisted closure of wound in pressure sores, skin grafting, wound dehiscence and other wounds have been published.16,17,18

The Advantages of VAHCD that we have noticed are-

  • Can be done on an outpatient basis as the regular dressings.
  • Regular wound dressing is not required.
  • Rate of granulation is faster and decreases the duration of hospital stay.
  • Wound contamination is prevented.
  • Compliance of the patient is good.

CONCLUSION

Vacuum-Assisted Hydrocolloid Dressing is an efficient and overall cost-effective method in management of chronic ulcers.



 

Videos :

watch?v